Dried Blood SPOT Analysis of Everolimus in Cancer Patients (SPOT-study)

NCT02809404 · clinicaltrials.gov ↗

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Renal Cell Carcinoma

Interventions

DRUG: Everolimus

Sponsor

Radboud University Medical Center